Bistos: Q1 2026 Net Loss Narrows, Liquidity Boosted via Convertible Bond Issuance

Q1 2026 revenue: KRW 2.97bn (down 20% YoY from KRW 3.71bn)
Net loss: KRW 0.30bn (improved from KRW 0.55bn loss in Q1 2025)
Cash & cash equivalents: KRW 3.78bn (substantial increase from KRW 0.40bn at year-end 2025)
Issued 2nd private convertible bond: KRW 4bn (coupon 3%, conversion price KRW 920, maturity 2029)
Change in largest shareholder: CU Medical System acquired 33.88% stake (Jan 20, 2026)
Provided Tiway Air perpetual convertible bond (KRW 2bn) as collateral for CB
Trading suspended after report filing for stock split (from Apr 24, 2026)